Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which airway device is best for kids? new study aims to find out

NCT ID NCT07274280

Knowledge-focused Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study compares three different breathing tube devices (Ambu AuraGain, LarySeal Pro LMA, and i-gel) used in children aged 2-9 years during day surgery. The goal is to see which one provides the best seal, causes fewest complications, and is easiest for doctors to insert. 165 children will take part, and the results will help guide safer anesthesia practices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supraglottic airway device
What this could lead to
If successful, this study could help doctors choose the best airway device for children, improving safety and reducing complications during surgery.
What could go wrong
This is a small, early-stage comparison trial, not a test of a new treatment. Results may not apply to all children or surgeries, and no device is risk-free.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

165 people

The number who actually took part.

Started

Jan 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 9 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Age 2-9 years. * Weight 10-30 kg. * ASA Physical Status I or II. * Elective day-case surgery requiring general anesthesia with controlled ventilation using an SGAD. * Written informed consent from parent(s) or legal guardian(s). Exclusion Criteria: * • ASA Physical Status III or IV. * Known or predicted difficult airway. * History of significant respiratory disease (e.g., asthma requiring frequent medication, active upper respiratory tract infection, reactive airway disease within the past month). * History of significant gastroesophageal reflux, hiatal hernia, BMI ≥ 35, or other conditions predisposing to increased aspiration risk. * Neuromuscular disorders affecting airway patency or respiratory function. * Known allergy or contraindication to study devices or anesthetic medications. * Participation in other clinical trials that could influence study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway control are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Airway control

Contacts and locations

Locations

  • KasrAlainy Hospitals

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.